Estimation of Inhibitory Effect against Tyrosinase Activity through Homology Modeling and Molecular Docking

Tyrosinase is a key enzyme in melanogenesis. Generally, mushroom tyrosinase from A. bisporus had been used as a model in skin-whitening agent tests employed in the cosmetic industry. The recently obtained crystal structure of bacterial tyrosinase from B. megaterium has high similarity (33.5%) to the human enzyme and thus it was used as a template for constructing of the human model. Binding of tyrosinase to a series of its inhibitors was simulated by automated docking calculations. Docking and MD simulation results suggested that N81, N260, H263, and M280 are involved in the binding of inhibitors to mushroom tyrosinase. E195 and H208 are important residues in bacterial tyrosinase, while E230, S245, N249, H252, V262, and S265 bind to inhibitors and are important in forming pi interaction in human tyrosinase.

[1]  Jinhyuk Lee,et al.  The Effect of Thiobarbituric Acid on Tyrosinase: Inhibition Kinetics and Computational Simulation , 2011, Journal of biomolecular structure & dynamics.

[2]  Jinhyuk Lee,et al.  Computational Prediction of Protein-Protein Interactions of Human Tyrosinase , 2012, Enzyme research.

[3]  K. Kong,et al.  Expression and characterization of human tyrosinase from a bacterial expression system. , 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[4]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[5]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[6]  Huacan Song,et al.  Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase. , 2011, European journal of medicinal chemistry.

[7]  G. S. Gukasyan Study of the Kinetics of Oxidation of Monophenols by Tyrosinase. The Effect of Reducers , 2002, Biochemistry (Moscow).

[8]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[9]  Ayelet Fishman,et al.  First structures of an active bacterial tyrosinase reveal copper plasticity. , 2011, Journal of molecular biology.

[10]  Y. Wan,et al.  1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. , 2008, Bioorganic & medicinal chemistry.

[11]  Hiromi Oozeki,et al.  Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton. , 2008, Bioorganic & medicinal chemistry letters.

[12]  M. Ganjali,et al.  The inhibitory effect of ethylenediamine on mushroom tyrosinase. , 2012, International journal of biological macromolecules.

[13]  F. García-Cánovas,et al.  Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. , 1993, The Biochemical journal.

[14]  I. Orhan,et al.  In silico approach to inhibition of tyrosinase by ascorbic acid using molecular docking simulations. , 2014, Current topics in medicinal chemistry.

[15]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[16]  Jerry Tan,et al.  Psychosocial impact of acne vulgaris: evaluating the evidence. , 2004, Skin therapy letter.

[17]  M. Sendovski,et al.  Directed evolution of tyrosinase for enhanced monophenolase/diphenolase activity ratio , 2010 .

[18]  M. Saloheimo,et al.  Bacterial tyrosinases and their applications , 2012 .

[19]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[20]  M. Marshall,et al.  Inhibition mechanism of kojic acid on polyphenol oxidase , 1991 .

[21]  Anan Abu Ubeid,et al.  Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase. , 2009, The Journal of investigative dermatology.

[22]  J. Buchert,et al.  Comparison of substrate specificity of tyrosinases from Trichoderma reesei and Agaricus bisporus , 2009 .

[23]  You-Jin Jeon,et al.  Molecular docking studies of a phlorotannin, dieckol isolated from Ecklonia cava with tyrosinase inhibitory activity. , 2012, Bioorganic & medicinal chemistry.

[24]  Hsiu-Mei Chiang,et al.  Tyrosol and Its Analogues Inhibit Alpha-Melanocyte-Stimulating Hormone Induced Melanogenesis , 2013, International journal of molecular sciences.

[25]  H. Decker,et al.  Bacterial tyrosinases. , 2006, Systematic and applied microbiology.

[26]  B. Dijkstra,et al.  Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. , 2011, Biochemistry.

[27]  A. Fishman,et al.  Isolation, Cloning and Characterization of a Tyrosinase with Improved Activity in Organic Solvents from Bacillus megaterium , 2009, Journal of Molecular Microbiology and Biotechnology.

[28]  D. Eisenberg,et al.  A method to identify protein sequences that fold into a known three-dimensional structure. , 1991, Science.

[29]  Te-Sheng Chang,et al.  An Updated Review of Tyrosinase Inhibitors , 2009, International journal of molecular sciences.

[30]  M. Litaudon,et al.  Tyrosinase inhibitors and sesquiterpene diglycosides from Guioa villosa. , 2008, Planta medica.

[31]  Emmanuel Mikros,et al.  Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors. , 2012, Bioorganic & medicinal chemistry letters.

[32]  L. Kolbe,et al.  4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[33]  D. M. Vera,et al.  Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans. , 2011, Bioorganic & medicinal chemistry.

[34]  J. Mccammon,et al.  Molecular Dynamics Simulations of a Polyalanine Octapeptide under Ewald Boundary Conditions: Influence of Artificial Periodicity on Peptide Conformation , 2000 .

[35]  R. Cao,et al.  Discovery of 4‐Functionalized Phenyl‐O‐β‐D‐glycosides as a New Class of Mushroom Tyrosinase Inhibitors. , 2010 .

[36]  J. Vaya,et al.  Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. , 2007, Journal of medicinal chemistry.

[37]  Ji Min Kim,et al.  Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors. , 2012, Biochimie.

[38]  R. Halder,et al.  Topical agents used in the management of hyperpigmentation. , 2004, Skin therapy letter.

[39]  P. Pithayanukul,et al.  Molecular Docking Studies and Anti-Tyrosinase Activity of Thai Mango Seed Kernel Extract , 2009, Molecules.

[40]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[41]  H. Iwasaki,et al.  Human tyrosinase inhibitor in rum distillate wastewater. , 2008, Journal of oleo science.

[42]  A. Lesk,et al.  The relation between the divergence of sequence and structure in proteins. , 1986, The EMBO journal.

[43]  Hwan-Suck Chung,et al.  Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries , 2007, Phytotherapy research : PTR.

[44]  K. Kong,et al.  Inhibitory Effects on L-Dopa Oxidation of Tyrosinase by Skin-whitening Agents , 2005 .

[45]  Jennifer K Inlow,et al.  Enzyme, protein, carbohydrate, and phenolic contaminants in commercial tyrosinase preparations: potential problems affecting tyrosinase activity and inhibition studies. , 2008, Journal of agricultural and food chemistry.

[46]  E. Jaenicke,et al.  A three-dimensional model of mammalian tyrosinase active site accounting for loss of function mutations. , 2007, Pigment cell research.

[47]  J. R. A. Silva,et al.  Combined Kinetic Studies and Computational Analysis on Kojic Acid Analogs as Tyrosinase Inhibitors , 2014, Molecules.